Long Term Effeictiveness of Treatment With Stimulants in ADHD

*Long-Term Stimulant Medication Treatment of
Attention-Deficit/Hyperactivity Disorder: Results from a
Population-Based Study.*

J Dev Behav Pediatr. 2006 Feb;27(1):1-10

Authors: Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL,
Jacobsen SJ

ABSTRACT.: The purpose of this study was to offer detailed information
about stimulant medication treatment provided throughout childhood to
379 children with research-identified attention-deficit hyperactivity
disorder (ADHD) in the 1976-1982 Rochester, MN, birth cohort. Subjects
were retrospectively followed from birth until a mean of 17.2 years of
age. The complete medical record of each subject was reviewed. The
history and results of each episode of stimulant treatment were compared
by gender, DSM-IV subtype of ADHD, and type of stimulant medication.
Overall, 77.8% of subjects were treated with stimulants. Boys were
1.8 times more likely than girls to be treated. The median age at
initiation (9.8 years), median duration of treatment (33.8 months), and
likelihood of developing at least one side effect (22.3%) were not
significantly different by gender. Overall, 73.1% of episodes of
stimulant treatment were associated with a favorable response. The
likelihood of a favorable response was comparable for boys and girls.
Treatment was initiated earlier for children with either ADHD combined
type or ADHD hyperactive-impulsive type than for children with ADHD
predominantly inattentive type and duration of treatment was longer for
ADHD combined type. There was no association between DSM-IV subtype and
likelihood of a favorable response or of side effects. Dextroamphetamine
and methylphenidate were equally likely to be associated with a
favorable response, but dextroamphetamine was more likely to be
associated with side effects. These results demonstrate that the
effectiveness of stimulant medication treatment of ADHD provided
throughout childhood is comparable to the efficacy of stimulant
treatment demonstrated in clinical trials.

PMID: 16511362 [PubMed - as supplied by publisher]

"Raving Loonie" wrote in message
oups.com...
Mark Probert wrote:
*Long-Term Stimulant Medication Treatment of
Attention-Deficit/Hyperactivity Disorder: Results from a
Population-Based Study.*

[snip]

YAUS (Yet Another Useless Study )

Pharmacological and Environmental factors have not been delinked.


Raving Loonie

That was not the purpose of the study.

Jeff

Jeff wrote:
"Raving Loonie" wrote in message
oups.com...
Mark Probert wrote:
*Long-Term Stimulant Medication Treatment of
Attention-Deficit/Hyperactivity Disorder: Results from a
Population-Based Study.*

[snip]

YAUS (Yet Another Useless Study )

Pharmacological and Environmental factors have not been delinked.


Raving Loonie

That was not the purpose of the study.
Yeah. ... So?

Field results = Clinical results

That's nice.

It also is consistent with ...

Clinical 'Attitude' = Popular (public, lay ) 'Attitude'

In other words ...
Clinical setting and public settings are equivalent.

I claim ...

Pharmacological and Environmental factors have not been delinked.

Cordially,

RL